Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Swedish Orphan Biovitrum AB (publ)
OTC:SWOBY
|
SE |
|
T
|
Tompkins Financial Corp
AMEX:TMP
|
US |
Wall St Price Targets
SWOBY Price Targets Summary
Swedish Orphan Biovitrum AB (publ)
According to Wall Street analysts, the average 1-year price target for
SWOBY is 25.02 USD with a low forecast of 16.59 USD and a high forecast of 30.8 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SWOBY's stock price target?
Price Target
25.02
USD
According to Wall Street analysts, the average 1-year price target for
SWOBY is 25.02 USD with a low forecast of 16.59 USD and a high forecast of 30.8 USD.
What is the Revenue forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 23%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 27%. The projected CAGR for the next 8 years is 9%.
What is the Operating Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
600%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 600%.
What is the Net Income forecast for Swedish Orphan Biovitrum AB (publ)?
Projected CAGR
43%
The compound annual growth rate for Net Income over the next 8 years is 43%.